GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Other Current Receivables

SillaJen (XKRX:215600) Other Current Receivables : ₩780 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is SillaJen Other Current Receivables?

SillaJen's Other Current Receivables for the quarter that ended in Mar. 2025 was ₩780 Mil.

SillaJen's quarterly Other Current Receivables increased from Sep. 2024 (₩345.21 Mil) to Dec. 2024 (₩564.10 Mil) and increased from Dec. 2024 (₩564.10 Mil) to Mar. 2025 (₩780.48 Mil).

SillaJen's annual Other Current Receivables declined from Dec. 2022 (₩1,048.55 Mil) to Dec. 2023 (₩330.54 Mil) but then increased from Dec. 2023 (₩330.54 Mil) to Dec. 2024 (₩564.10 Mil).


SillaJen Other Current Receivables Historical Data

The historical data trend for SillaJen's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SillaJen Other Current Receivables Chart

SillaJen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,222.45 394.51 1,048.55 330.54 564.10

SillaJen Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 664.96 440.98 345.21 564.10 780.48

SillaJen Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


SillaJen Other Current Receivables Related Terms

Thank you for viewing the detailed overview of SillaJen's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


SillaJen Business Description

Traded in Other Exchanges
N/A
Address
6F, 252, Geumjeong-ro, Geumjeong-gu, Busan, KOR, 46274
SillaJen Inc is a Korean based biotechnology company focused on engineering and developing cancer treatment cells. The company along with its subsidiary SillaJen Biotherapeutics, Inc offers Pexa-Vec, an oncolytic virus with antibodies, and improved survival in a randomized trial to cure cancer; and JX929, an engineered vaccinia virus strain that acts on cancer cells by viral attack and subsequent cancer cell oncolysis. SillaJen operates its business activities in Korea and United States.

SillaJen Headlines

No Headlines